Concepedia

Matthew A. Kutny

MA

15

Publications

624

Citations

14

H-Index

2011

Active since

Affiliations

University of Alabama at Birmingham(Current)

Fred Hutch Cancer Center

Goryeb Children's Hospital

Atlantic Health System

University of Southern California

Matthew A. Kutny is an author at University of Alabama at Birmingham specializing in medicine, hematology, and cancer research.

ORCID

Top concepts

Publications per year

2011–2025

15

Publications

15

Leukemic mutations in the methylation‐associated genes <i>DNMT3A</i> and <i>IDH2</i> are rare events in pediatric AML: A report from the Children's Oncology Group

Phoenix A. Ho, Matthew A. Kutny, Todd A. Alonzo et al. · Pediatric Blood & Cancer · 2011 · 122 citations

Assessment of Arsenic Trioxide and All-trans Retinoic Acid for the Treatment of Pediatric Acute Promyelocytic Leukemia

Matthew A. Kutny, Todd A. Alonzo, Oussama Abla et al. · JAMA Oncology · 2021 · 91 citations · Full text

Arsenic Trioxide Consolidation Allows Anthracycline Dose Reduction for Pediatric Patients With Acute Promyelocytic Leukemia: Report From the Children's Oncology Group Phase III Historically Controlled Trial AAML0631

Matthew A. Kutny, Todd A. Alonzo, Robert B. Gerbing et al. · Journal of Clinical Oncology · 2017 · 88 citations · Full text

, , +15

FLT3 mutation status is a predictor of early death in pediatric acute promyelocytic leukemia: A report from the Children's Oncology Group

Matthew A. Kutny, Barry Kurt Moser, Kristina Laumann et al. · Pediatric Blood & Cancer · 2012 · 53 citations · Full text

Characteristics and prognostic impact of<i>IDH</i>mutations in AML: a COG, SWOG, and ECOG analysis

Sara Zarnegar‐Lumley, Todd A. Alonzo, Robert B. Gerbing et al. · Blood Advances · 2023 · 51 citations · Full text

Rows per page

1–5 of 15